These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 8298164

  • 21. [Antitumor effect of intermittent oral administration of UFT against human rectal cancer xenografted in nude mice].
    Yamada K, Takao S, Ishizawa T, Shimazu H.
    Gan To Kagaku Ryoho; 1988 Feb; 15(2):291-6. PubMed ID: 3124769
    [Abstract] [Full Text] [Related]

  • 22. [Evaluation of UFT administration in patients with ovarian cancer who had no evidence of disease after the initial therapy].
    Chen JT, Nakayama K, Shimizu Y, Yokosuka K, Teshima H, Hirai Y, Hamada T, Fujimoto I, Yamauchi K, Hasumi K.
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):407-12. PubMed ID: 2106837
    [Abstract] [Full Text] [Related]

  • 23. Effect of gastrectomy on the pharmacokinetics of tegafur, uracil, and 5-fluorouracil after oral administration of a 1:4 tegafur and uracil combination.
    Maehara Y, Takeuchi H, Oshiro T, Takahashi I, Inutsuka S, Baba H, Kohnoe S, Sugimachi K.
    Cancer Chemother Pharmacol; 1994 Mar; 33(6):445-9. PubMed ID: 8137453
    [Abstract] [Full Text] [Related]

  • 24. Augmentation of the chemotherapeutic effectiveness of UFT, a combination of tegafur [1-(2-tetrahydrofuryl)-5-fluorouracil] with uracil, by oral l-leucovorin.
    Okabe H, Toko T, Saito H, Nakano K, Fujioka A, Yuasa C, Takeda S, Unemi N.
    Anticancer Res; 1997 Mar; 17(1A):157-64. PubMed ID: 9066646
    [Abstract] [Full Text] [Related]

  • 25. [A study on plasma and tissue 5-FU concentrations in patients with cervical cancer treated with UFT].
    Kawai Y, Hirano H, Taniguchi H, Nishiyama M, Yanase H, Uematsu A, Sugiyama Y.
    Nihon Gan Chiryo Gakkai Shi; 1985 Apr 20; 20(3):592-6. PubMed ID: 3932563
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Preoperative treatment with UFT for patients with ovarian malignant tumors].
    Nagai S, Sawada T, Tsukasaki K, Kamiya H, Sakai K.
    Gan To Kagaku Ryoho; 1985 May 20; 12(5):1073-9. PubMed ID: 3922309
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. In vivo 19F NMR comparative study of 5-fluorouracil, 1-(2-tetrahydrofuryl)-5-fluorouracil (FT) and an FT-uracil coadministration system in mouse tumors.
    Kanazawa Y, Kurogi S, Shinohara S, Noda Y, Masuda K.
    Chem Pharm Bull (Tokyo); 1994 Apr 20; 42(4):774-8. PubMed ID: 8020119
    [Abstract] [Full Text] [Related]

  • 30. Effects of beta-carotene-rich algae Dunaliella bardawil on the dynamic changes of normal and neoplastic mammary cells and general metabolism in mice.
    Fujii Y, Sakamoto S, Ben-Amotz A, Nagasawa H.
    Anticancer Res; 1993 Apr 20; 13(2):389-93. PubMed ID: 8517652
    [Abstract] [Full Text] [Related]

  • 31. Human colorectal malignancy and oral UFT.
    Sakamoto S, Tsukada K, Sagara T, Kawachi Y, Murakami S, Iwama T.
    Anticancer Res; 2002 Apr 20; 22(1A):339-41. PubMed ID: 12017314
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Enhanced accumulation of 5-fluorouracil in human tumors in athymic mice by co-administration of Ftorafur and uracil.
    Tang SG, Hornbeck CL, Byfield JE.
    Int J Radiat Oncol Biol Phys; 1984 Sep 20; 10(9):1687-9. PubMed ID: 6434499
    [Abstract] [Full Text] [Related]

  • 35. [Effect of calmodulin antagonists (W-5 and W-7) on antitumor activity of Tegafur and UFT (Tegafur plus uracil)].
    Kikuchi Y, Oomori K, Iwano I, Kizawa I, Miyauchi M, Kita T, Kato K.
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Apr 20; 40(4):422-8. PubMed ID: 3131462
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Oral fluoropyrimidines in the treatment of advanced colorectal cancer--results of two consecutive phase II trials.
    Adimi P, Hansen F, Kjaer M, Aabo K, Keldsen N, Pfeiffer P, Sandberg E, Jakobsen A.
    Acta Oncol; 2002 Apr 20; 41(2):202-3. PubMed ID: 12102169
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Blood levels of 5-FU and uracil on additional use of uracil in UFT therapy in gastrectomized patients].
    Suda Y, Uchida K.
    Gan To Kagaku Ryoho; 1995 Sep 20; 22(10):1343-7. PubMed ID: 7668868
    [Abstract] [Full Text] [Related]

  • 40. [Clinical experiences with UFD-1].
    Furue H.
    Gan To Kagaku Ryoho; 1982 Apr 20; 9(4):672-4. PubMed ID: 6820905
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.